Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
2008 ◽
Vol 27
(9)
◽
pp. 790-797
◽
2014 ◽
Vol 109
◽
pp. S178